A closed meeting of the National Institute of Allergy and Infectious Diseases (NIAID) Special Emphasis Panel will be held August 24-25, 2023 to review and evaluate contract proposals for the NIAID 2023 DMID Omnibus BAA (HHS–NIH–NIAID–BAA2023–1), Research Area 004—Development of In Vitro Diagnostics for Biodefense, Antimicrobial Resistant Infections, and Emerging Infectious Diseases (N01). The meeting
Advertisement
35 events found.
Calendar of Events
|
M
Mon
|
T
Tue
|
W
Wed
|
T
Thu
|
F
Fri
|
S
Sat
|
S
Sun
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
1 event,
|
0 events,
|
0 events,
|
|
|
1 event,
Virtual Event
-
Virtual Event
The National Biodefense Science Board (NBSB) will convene for a virtual meeting on 28 August 2023. The NBSB provides expert advice and guidance to the U.S. Department of Health and Human Services and the Assistant Secretary of Preparedness and Response regarding current and future chemical, biological, radiological, and nuclear threats, as well as other matters |
0 events,
|
0 events,
|
0 events,
|
1 event,
-
NIAID Review of BAA Proposals for Vaccine Candidates for Biodefense and Emerging Infectious Diseases
NIAID Review of BAA Proposals for Vaccine Candidates for Biodefense and Emerging Infectious Diseases
A closed meeting of the National Institute of Allergy and Infectious Diseases (NIAID) Special Emphasis Panel will be held September 1, 2023 to review and evaluate contract proposals for the NIAID 2023 DMID Omnibus BAA (HHS–NIH–NIAID–BAA2023–1), Research Area 001—Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases. The meeting will be closed to the |
0 events,
|
0 events,
|